Trial Profile
Phase 1/2 Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells Infusion for Promotion of Engraftment and Prevention of an Graft Rejection and Graft-versus-Host Disease After Unrelated Hematopoietic Stem Cell Transplantation.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Mesenchymal stem cell therapy (Primary)
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- Sponsors Medipost
- 22 Dec 2015 New trial record